VHL SYNDROME
Clinical trials for VHL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VHL SYNDROME trials appear
Sign up with your email to follow new studies for VHL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare kidney cancer in VHL patients
Disease control OngoingThis phase 2 trial is testing a daily pill called belzutifan in 50 people with VHL disease who have kidney cancer. The goal is to see if the drug can shrink tumors. Researchers are also monitoring how long any tumor shrinkage lasts and checking for side effects.
Matched conditions: VHL SYNDROME
Phase: PHASE2 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Scientists map hidden tumor diversity in rare kidney cancer
Knowledge-focused OngoingThis study aims to understand why kidney tumors in people with VHL syndrome can be different from each other. Researchers will use advanced imaging, multiple biopsies, and lab-grown tumor models to map these differences. The goal is to learn more about the disease, not to test a …
Matched conditions: VHL SYNDROME
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC